-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target

Benzinga·11/19/2025 13:09:25
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.